Form 4: Northwest Biotherapeutics Executive Gifts 1 Million Shares for Estate Planning
SEC Form 4
Alton L. Boynton, Chief Scientific Officer of Northwest Biotherapeutics, gifted 1,000,000 stock options to family members for estate planning purposes on August 8, 2024.
Summary
- On August 8, 2024, Alton L. Boynton, the Chief Scientific Officer of Northwest Biotherapeutics Inc. (NWBO), reported a transaction involving derivative securities.
- Boynton gifted 1,000,000 stock options with an exercise price of $0.23 to family members who do not share the same residence.
- The options, originally granted on August 31, 2018, and expiring on August 31, 2028, are exercisable into 1,000,000 shares of common stock with a par value of $0.001.
- Following the transaction, Boynton directly owns 1,967,065 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock options transfer for estate planning, with no inherent positive or negative implications for the company's performance.
Industry Context
Executive stock option grants and transfers are common in the biopharmaceutical industry as part of compensation and estate planning.
Stakeholder Impact
- The gift of stock options may have a minor impact on the ownership structure of the company.
Key Dates
| Date | Description |
|---|---|
| 08/31/2018 | Original grant date of the stock options |
| 08/08/2024 | Date of the gift transaction |
| 08/08/2024 | Date of Form 4 filing |
| 08/31/2028 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.